NextCure

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NextCure and other ETFs, options, and stocks.

About NXTC

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. 

CEO
Michael S. Richman
CEOMichael S. Richman
Employees
87
Employees87
Headquarters
Beltsville, Maryland
HeadquartersBeltsville, Maryland
Founded
2015
Founded2015
Employees
87
Employees87

NXTC Key Statistics

Market cap
76.59M
Market cap76.59M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
64.43K
Average volume64.43K
High today
$2.86
High today$2.86
Low today
$2.75
Low today$2.75
Open price
$2.80
Open price$2.80
Volume
42.77K
Volume42.77K
52 Week high
$9.18
52 Week high$9.18
52 Week low
$2.66
52 Week low$2.66

Analyst ratings

63%

of 8 ratings
Buy
62.5%
Hold
25%
Sell
12.5%

NXTC Earnings

-$0.75
-$0.50
-$0.25
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.